Clinical Trial Detail

NCT ID NCT03116971
Title Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

lung small cell carcinoma

Therapies

MSC2490484A + Cisplatin + Etoposide

MSC2490484A

Age Groups: adult senior

No variant requirements are available.